Cargando…

Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis

This study evaluated the levels of two amino acid derivatives taurine and spermine in first-episode psychosis (FEP) patients and their response to antipsychotic treatment. The levels of taurine and spermine were significantly up-regulated in antipsychotic-naïve FEP patients compared to control subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Koido, Kati, Innos, Jürgen, Haring, Liina, Zilmer, Mihkel, Ottas, Aigar, Vasar, Eero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945631/
https://www.ncbi.nlm.nih.gov/pubmed/27471446
http://dx.doi.org/10.3389/fnins.2016.00331
_version_ 1782442898442158080
author Koido, Kati
Innos, Jürgen
Haring, Liina
Zilmer, Mihkel
Ottas, Aigar
Vasar, Eero
author_facet Koido, Kati
Innos, Jürgen
Haring, Liina
Zilmer, Mihkel
Ottas, Aigar
Vasar, Eero
author_sort Koido, Kati
collection PubMed
description This study evaluated the levels of two amino acid derivatives taurine and spermine in first-episode psychosis (FEP) patients and their response to antipsychotic treatment. The levels of taurine and spermine were significantly up-regulated in antipsychotic-naïve FEP patients compared to control subjects (CS). Treatment of FEP patients with antipsychotic drugs significantly reduced the positive symptoms of schizophrenia. This positive effect was accompanied by a significant reduction of taurine and spermine to the levels measured in CS. General linear model was used to establish associations of taurine and spermine with the levels of cytokines and growth factors, measured in our previous experiments using the same study sample. There was a strong association between taurine and epidermal growth factor (EGF). Both biomarkers significantly correlated with the disease symptoms as well as with the effectiveness of antipsychotic treatment. Accordingly one can conclude that taurine and EGF belong to the signature of FEP. Most probably they reflect altered oxidative stress and corrupted function of N-methyl-D-aspartate (NMDA) receptors in FEP.
format Online
Article
Text
id pubmed-4945631
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49456312016-07-28 Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis Koido, Kati Innos, Jürgen Haring, Liina Zilmer, Mihkel Ottas, Aigar Vasar, Eero Front Neurosci Pharmacology This study evaluated the levels of two amino acid derivatives taurine and spermine in first-episode psychosis (FEP) patients and their response to antipsychotic treatment. The levels of taurine and spermine were significantly up-regulated in antipsychotic-naïve FEP patients compared to control subjects (CS). Treatment of FEP patients with antipsychotic drugs significantly reduced the positive symptoms of schizophrenia. This positive effect was accompanied by a significant reduction of taurine and spermine to the levels measured in CS. General linear model was used to establish associations of taurine and spermine with the levels of cytokines and growth factors, measured in our previous experiments using the same study sample. There was a strong association between taurine and epidermal growth factor (EGF). Both biomarkers significantly correlated with the disease symptoms as well as with the effectiveness of antipsychotic treatment. Accordingly one can conclude that taurine and EGF belong to the signature of FEP. Most probably they reflect altered oxidative stress and corrupted function of N-methyl-D-aspartate (NMDA) receptors in FEP. Frontiers Media S.A. 2016-07-15 /pmc/articles/PMC4945631/ /pubmed/27471446 http://dx.doi.org/10.3389/fnins.2016.00331 Text en Copyright © 2016 Koido, Innos, Haring, Zilmer, Ottas and Vasar. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Koido, Kati
Innos, Jürgen
Haring, Liina
Zilmer, Mihkel
Ottas, Aigar
Vasar, Eero
Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
title Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
title_full Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
title_fullStr Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
title_full_unstemmed Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
title_short Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
title_sort taurine and epidermal growth factor belong to the signature of first-episode psychosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945631/
https://www.ncbi.nlm.nih.gov/pubmed/27471446
http://dx.doi.org/10.3389/fnins.2016.00331
work_keys_str_mv AT koidokati taurineandepidermalgrowthfactorbelongtothesignatureoffirstepisodepsychosis
AT innosjurgen taurineandepidermalgrowthfactorbelongtothesignatureoffirstepisodepsychosis
AT haringliina taurineandepidermalgrowthfactorbelongtothesignatureoffirstepisodepsychosis
AT zilmermihkel taurineandepidermalgrowthfactorbelongtothesignatureoffirstepisodepsychosis
AT ottasaigar taurineandepidermalgrowthfactorbelongtothesignatureoffirstepisodepsychosis
AT vasareero taurineandepidermalgrowthfactorbelongtothesignatureoffirstepisodepsychosis